Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-09Clinical Trial Update: Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis [NA]
This document notes that the clinical trial on a multidisciplinary, treat-to-target approach for rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Dysphagia in Rheumatoid Arthritis
A clinical trial at Tanta University is evaluating dysphagia in patients with rheumatoid arthritis and is currently recruiting.
-
FDA approval · 2026-03-06FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XELJANZ XR (tofacitinib) from Pfizer Laboratories Div Pfizer Inc, introducing the extended-r…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Phone-Based Based Walk With Ease Program for Adults With Arthritis [NA]
Completed clinical trial evaluating a phone-based Walk With Ease program for adults with arthritis, with results posted.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease [Phase 1]
Phase 1 study of S-4321 in autoimmune and immune-mediated diseases; the trial status is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Rheumatoid Arthritis Shared Decision Making [NA]
A completed clinical trial evaluating shared decision making in the management of rheumatoid arthritis (NCT05530694).
-
EMA approval · 2026-03-05EMA Authorised: Simponi (golimumab) — Janssen Cilag International NV
The European Medicines Agency authorised Simponi (golimumab) for multiple inflammatory conditions including rheumatoid arthritis, psoriatic …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis [Phase 1, Phase 2]
A Phase 1/2 clinical trial update comparing B-cell depletion by rituximab with anti-CD19 CAR-T therapy in patients with rheumatoid arthritis…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis [Phase 2]
A Phase II clinical trial investigating SHR-3045 Injection for rheumatoid arthritis is currently recruiting.
-
CLINICAL_TRIALS other · 2026-03-05Clinical Trial Update: Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of Ivarmacitinib as monotherapy for rheumatoid arthritis patients not adequately…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Association of Pain With Body Image and Psychological Resilience in Rheumatoid Arthritis and Fibromyalgia
This completed clinical trial from Samsun University studied the association between pain, body image, and psychological resilience in indiv…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Kinesiophobia in Rheumatoid Arthritis: Associations With Functional Disability, Disease Activity, and Related Clinical Factors
This clinical trial update outlines a study on kinesiophobia (fear of movement) in rheumatoid arthritis and its associations with functional…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: DEXA Bone Density Analysis of the CoreHip® Prosthesis System [NA]
A clinical trial update on DEXA bone-density analysis for the CoreHip prosthesis, with NOT_YET_RECRUITING status and conditions including hi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
Aesculap AG is evaluating medium cross-linked polyethylene with and without vitamin E for use in total knee arthroplasty; the trial is curre…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: HiSCs in the Treatment of Rheumatoid Arthritis [NA]
This clinical trial update notes a study evaluating human-induced stem cells (HiSCs) as a treatment for rheumatoid arthritis, sponsored by S…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT [NA]
A randomized 12-week trial comparing Mediterranean to Paleolithic diets in rheumatoid arthritis to evaluate disease activity, sarcopenia, an…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
PHENO4U data platform is being evaluated in patients undergoing total knee arthroplasty; the study is currently recruiting.
-
EMA approval · 2026-02-25EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG
The EMA authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, juvenil…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory clinical study evaluating the safety and potential efficacy of an anti-CD19/BCMA U CAR-T cell therapy for relapse…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases [Phase 2]
This Phase 2 master protocol trial, sponsored by Amgen, is evaluating Inebilizumab and Blinatumomab in autoimmune diseases. It is currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Cemented TrendHip® - Multicenter PMCF Study on Total Indications [NA]
PMCF study update for the cemented TrendHip hip prosthesis across multiple indications. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis [Phase 1, Phase 2]
Clinical trial update on BMS-986528 for refractory rheumatoid arthritis, a Phase 1/2 study sponsored by Bristol-Myers Squibb. The trial is c…
-
EMA approval · 2026-02-20EMA Authorised: Kevzara (sarilumab) — Sanofi Winthrop Industrie
The EMA has authorised Kevzara (sarilumab) for rheumatoid arthritis in the European Union.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD [Phase 2]
A Phase IIb clinical trial is planned to evaluate the efficacy and safety of GenSci120 Injection in adults with moderately to severely activ…
-
EMA approval · 2026-02-19EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Hulio, a biosimilar of adalimumab, for multiple inflammatory indications including hidradenitis suppurativa, psoriasis, u…